The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer: A Systematic Review
BACKGROUND: Cholangiocarcinoma and gallbladder cancer are difficult to treat curatively. The treatment of choice is surgery, dependent on detection at a resectable stage. No chemotherapy or radiotherapy options have shown substantial activity. Gemcitabine has demonstrated response in similar cancers...
Saved in:
Main Authors: | Brian H Dingle, R Bryan Rumble, Melissa C Brouwers |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2005-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2005/565479 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment and characterization of three gemcitabine-resistant human intrahepatic cholangiocarcinoma cell lines
by: Jiandong Li, et al.
Published: (2025-02-01) -
Enhanced expression of ten‐eleven translocation 1 reverses gemcitabine resistance in cholangiocarcinoma accompanied by a reduction in P‐glycoprotein expression
by: Chuanxu Wang, et al.
Published: (2019-03-01) -
Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
by: Methi Wathikthinnakon, et al.
Published: (2022-04-01) -
Umbrella review of adjuvant photodynamic therapy for cholangiocarcinoma palliative treatment
by: Hanhan Chen, et al.
Published: (2025-02-01) -
Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
by: Methi Wathikthinnakon, et al.
Published: (2025-02-01)